Lindsay Androski

Lindsay Androski

President and Chief Executive OfficeratArbutus Biopharma· In proxies 2024–2025

Pay in FY2025Arbutus Biopharma stock +47.1% the same year

Lindsay Androski was paid $1.4M in FY2025 (Dec). Arbutus Biopharma stock rose 47.1% that year.

Pay$100 in the stock at the end of FY23 → $192
Pay is from the Summary Compensation Table of each Arbutus Biopharma proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Arbutus BiopharmaPublic company · 2 yr
    • President and Chief Executive Officer2024 – Present · 2 yrStock in role +81%

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?